Physician profile
Laura Bohatch
NPI 1942681226
$4,027.84
in general payments reported to CMS, 2019-2025
39 companies · $960 in 2025
The $960 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $27.02 · 2021: $208 · 2022: $1,060 · 2023: $560 · 2024: $1,075 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,594.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $724.20 | 2021-2025 | Qulipta, Ubrelvy |
| Novo Nordisk INC | $700.49 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $471.11 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $303.45 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $236.11 | 2023-2025 | |
| Amgen INC. | $228.69 | 2021-2025 | Repatha, Evenity, Otezla |
| Merck Sharp & Dohme LLC | $138.77 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Novartis Pharmaceuticals Corporation | $133.64 | 2019-2024 | |
| Lundbeck LLC | $117.79 | 2023-2025 | Rexulti |
| Grt US Holding, INC. | $98.46 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.53 | 2019-2022 | |
| Radius Health, INC. | $62.45 | 2022-2023 | Tymlos |
| Sumitomo Pharma America, INC. | $53.44 | 2024 | Gemtesa |
| Exact Sciences Corporation | $51.89 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $49.30 | 2019-2024 | Watchman Flx |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Bohatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.